Jan 12, 2021 / 02:10PM GMT
Robert Justin Marcus - JPMorgan Chase & Co, Research Division - Analyst
Welcome, everyone. I'm Robbie Marcus, med-tech analyst at JPMorgan. I'm very happy to have Insulet for our next presentation. We're going to have CEO, Shacey Petrovic, lead the presentation and Q&A.
Just some housekeeping reminders. Go ahead to the health care website, and you can follow along with the slide deck to Shacey's remarks. Also, you can e-mail a question to me, and I can ask it in Q&A,or submit a question on the conference website, and I'll do my best to ask in Q&A.
So with that, Shacey, take it away.
Shacey Petrovic - Insulet Corporation - President, CEO & Director
Great. Thanks, Robbie. It's great to be here with you and to have the opportunity to share Insulet's great growth story with everyone. If we could open up the presentation? Great.
So Insulet, for those of you that are not familiar, is a company centered on a simple but powerful mission to improve the lives of people living with diabetes. We are the manufacturer of the
Insulet Corp at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 12, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers